BioLineRx Ltd (BLRX)

[midastouch017]

BioLineRx to Report 2021 Annual Results on March 16, 2022

https://finance.yahoo.com/news/biolinerx-report-2021-annual-results-120000147.html

Management to hold a conference call at 10:00 a.m. EST

TEL AVIV, Israel, March 10, 2022 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX), (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, announced today it will release its audited financial results for the year ended December 31, 2021 on Wednesday, March 16, 2022, before the US markets open.

The Company will host a conference call on Wednesday, March 16, 2022 at 10:00 a.m. EST featuring remarks by Philip Serlin, Chief Executive Officer. The conference call will be available via webcast and can be accessed through the Investor Relations page of BioLineRx's website. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.

To dial into the conference call, please dial [phone] from the U.S. or [phone] internationally. A replay of the conference call will be available approximately two hours after completion of the live conference call on the Investor Relations page of BioLineRx's website. A dial-in replay of the call will be available until March 18, 2022; please dial [phone] from the U.S. or [phone] internationally.